Matthew L. Sherman, M.D.

Matthew L. Sherman, M.D.

DirectoratPalvella Therapeutics· In proxies 2023–2024

Matthew L. Sherman, M.D. sits on 3 public boards.

Experience

  1. Palvella TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +109%
  2. PierisPublic company
    • Director? – PresentNo stock prices for these years
  3. NewLink Genetics CorpPublic company
    • Director? – PresentNo stock prices for these years
  4. Pulmatrix, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?